Risankizumab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Risankizumab is a fully humanized IgG1 monoclonal antibody (mAb) that is selective for interleukin 23 (IL-23). On April 23, 2019 it was approved by the FDA (as SKYRIZI) for the
Risankizumab Recombinant Monoclonal Antibody for SPR, Flow, ELISA, Functional Risankizumab is a fully humanized IgG1 monoclonal antibody (mAb) that is selective for interleukin 23 (IL-23). On April 23, 2019 it was approved by the FDA (as SKYRIZI) for the
Read more ...